Doctor Care Anywhere : 2021 Annual Report and Corporate Governance Statement

Annual Report 2021

Doctor Care Anywhere Group PLC

(Company Number 08915336)

(ARBN 645 163 873)

doctor care anywhere annual report 2021

Shareholder Information 91

Corporate Directory 93

Contents

STRATEGIC REPORT

Chairman's Letter 2

CEO's Letter 4

Operating and Financial Review 8

REPORT OF THE DIRECTORS

Directors' Report 13

Corporate Governance Statement 19

Appendix A 31

Remuneration Chairman's Letter 32

Remuneration Report 33

Directors' Declaration 41

Directors' Responsibility Statement 42

FINANCIAL STATEMENTS

Financial Statements 43

Notes to the Financial Statements 50

Independent Auditor's Report 79

2 doctor care anywhere annual report 2021

Chairman's Letter

"Throughout 2021 Doctor Care Anywhere demonstrated its capacity for growth. The Company continues to perform well and has built robust foundations on which to strengthen its market position in 2022."

Reflections on 2021

In many ways 2021 proved to be more demanding for people, organisations and indeed health systems than 2020. Each new variant of COVID-19 created further uncertainty and dislocation with more social and economic upheaval.

It is against this background of challenge that I am pleased to report the Company has developed well. We have consolidated long-term customer partnerships, expanded into new geographies and, most importantly, have grown significantly the number of patients using our service. None of this could have been achieved without the commitment of colleagues from across the organisation who have continued to work tirelessly to support ever more patients with their health needs.

I have felt very privileged to chair an organisation with the potential of Doctor Care Anywhere. The leadership given by

Dr Bayju Thakar and his team and the efforts of everyone in the Company have placed it at the forefront of change to deliver tangible benefits to health systems which have been so under siege during the pandemic.

Meeting the challenges

The growth potential of our sector has never been in doubt but the complexities of scaling a business from delivering 20,000 consultations a month to nearly 50,000 consultations a month in just 12 months are considerable.

And yet the platform and the teams who have delivered this outcome have more than risen to this challenge. During a year in which many colleagues have been forced to work remotely for long periods of time it has been satisfying to see how well teams have pulled together to deliver for patients.

This sense of team and togetherness has never been more important in the context of delivering not just the provision of healthcare but a genuine health service. Patients have faced considerable challenges in their everyday lives and the Company's front line service teams have demonstrated a capacity for care which has gone beyond simple clinical requirements.

This commitment to our patients marks, in my view, the key point of difference for this organisation. Doctor Care Anywhere uniquely supports a patient's health journey through both primary and secondary healthcare. The private insurance market has never been more competitive and this approach is consolidating the Company's position as a reliable and forward thinking partner for some of the largest insurers in the world. At the same time, our emphasis on the patient experience means the Company is cementing these long-term relationships and building strong foundations for an exciting future.

Non-Executive Directors

We are fortunate to have enjoyed support throughout 2021 from an experienced and knowledgeable Board of Non-executive Directors from diverse backgrounds and geographies.

Romana Abdin, Simon Calver, Richard Dammery, David Ravech, Dr Leanne Rowe and Vanessa Wallace have each made substantial contributions to the successful execution of our strategy as we have progressed through the year.

Earlier this year, Dr Leanne Rowe stepped down from the Board for personal reasons. She remains a valued and trusted friend of the Company and we thank her for her support and expertise throughout our listing, and first few months as a listed organisation.

Summary

Your company delivered a strong performance in 2021, exceeding revenue guidance, consolidating relationships with key customers and expanding its international footprint through the acquisition of GP2U.

We have grown rapidly against the backdrop of the pandemic which has so challenged people around the world and most importantly, have supported in excess of 212,800 patients with their health needs.

My thanks go to all of our colleagues, customers, partners and patients who have made this possible. I am confident that we have built strong foundations and the momentum for future growth through 2022.

Jonathan Baines

Chairman